Over the past 10 years, Parker took on increased leadership roles at Mayo Clinic. His most recent positions included professor of epidemiology and urology, vice chair of health sciences research, associate director of the Center for Individualized Medicine, associate medical director of development and co-program leader for genetic epidemiology.
Parker is an outstanding scientist and an expert in the molecular epidemiology of renal cell carcinoma. He has presented his work widely and has published more than 100 papers, many in high-impact journals. His work has led to important practice changes, particularly around prognostic markers for the management of patients undergoing resection for renal cell carcinoma. His research has been supported by extramural funding from the National Cancer Institute, the Department of Defense and the James and Esther King Biomedical Research Program.
We are excited to welcome Parker, who will facilitate, mentor and further expand and develop new research programs at UF COMJ.
In terms of research funding, UF COMJ enjoyed a fruitful year in 2017-18. The college received $26.8 million in externally sponsored awards, a 25 percent increase over the previous fiscal year.
Funding from federal and federal flow-down awards accounted for 61 percent of all funding. UF COMJ ranks third among the university’s health colleges for fiscal year 2018 funding and sixth among all UF colleges. Over the past five years, UF COMJ has increased extramural sponsored programs funding by 119 percent.
The following chart gives a breakdown of the college’s various research funding sources for 2017-18.